Huijun Yang

发表

Interactive Mobile Health Intervention and Blood Pressure Management in Adults.

Fangchao Liu, Xiangfeng Lu, D. Gu, 2019, Hypertension.

CELL BIOLOGY AND SIGNALING

V. P. Collins, Michael A. Koldobskiy, R. Spang, 2010 .

TBX2 over-expression promotes nasopharyngeal cancer cell proliferation and invasion.

Hongyan Zhu, Guang-Yin Xu, Huijun Yang, 2017, Oncotarget.

MicroRNA-320b Modulates Cholesterol Efflux and Atherosclerosis

Xiangfeng Lu, D. Gu, Lai-yuan Wang, 2021, Journal of atherosclerosis and thrombosis.

Sarcoplasmic reticulum calcium ATPase, SRCA, gene expression in myocardial biopsies in dilated cardiomyopathy and suspected myocarditis, molecular/physiologic correlation

Huijun Yang, 1998 .

Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance

Webster K. Cavenee, William H. Yong, Kenta Masui, 2015, Proceedings of the National Academy of Sciences.

Overexpression of SOX2 promotes migration, invasion, and epithelial-mesenchymal transition through the Wnt/β-catenin pathway in laryngeal cancer Hep-2 cells

Yan Wang, L. Hui, Huijun Yang, 2014, Tumor Biology.

Targeted Therapy Resistance Mediated by Dynamic Regulation of Extrachromosomal Mutant EGFR DNA

S. Nelson, C. James, J. Heath, 2014, Science.

Regulates Acid Metabolism in Cancer by of the Cystine-Glutamate Antiporter xCT.

T. Cloughesy, P. Mischel, H. Christofk, 2017 .

Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug

T. Cloughesy, P. Mischel, Wei Zhang, 2021, bioRxiv.

NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling

V. Bafna, B. Ren, P. Mischel, 2019, Nature.

Strand-specific miR-28-3p and miR-28-5p have differential effects on nasopharyngeal cancer cells proliferation, apoptosis, migration and invasion

Huijun Yang, Geping Wu, Yan Lv, 2019, Cancer Cell International.

mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc.

Feng Liu, Ivan Babic, Paul S Mischel, 2013, Cell metabolism.

De-repression of PDGFRβ transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients.

Ivan Babic, Paul S Mischel, Harley I Kornblum, 2013, Cancer discovery.

An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers.

G. Hon, T. Cloughesy, P. Mischel, 2016, Cancer cell.

A Kinome-Wide RNAi Screen in Drosophila Glia Reveals That the RIO Kinases Mediate Cell Proliferation and Survival through TORC2-Akt Signaling in Glioblastoma

John B. Thomas, S. Vandenberg, P. Mischel, 2013, PLoS genetics.

mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT.

T. Cloughesy, P. Mischel, H. Christofk, 2017, Molecular cell.

Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment.

P. Mischel, T. Mizowaki, E. Kohmura, 2015, The Journal of clinical investigation.

Single-Cell Phosphoproteomics Resolves Adaptive Signaling Dynamics and Informs Targeted Combination Therapy in Glioblastoma.

Paul S Mischel, Timothy F Cloughesy, Kenta Masui, 2016, Cancer cell.

Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivity

K. Frazer, P. Mischel, V. Verkhusha, 2017, Genes & development.

SOX2 promotes the migration and invasion of laryngeal cancer cells by induction of MMP-2 via the PI3K/Akt/mTOR pathway.

Yan Wang, Huijun Yang, N. Yang, 2014, Oncology reports.

EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling.

Webster K. Cavenee, Bing Ren, Gary C. Hon, 2015, Molecular cell.

PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies

H. Okano, T. Cloughesy, P. Mischel, 2013, Proceedings of the National Academy of Sciences.

Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance.

Ivan Babic, Paul S Mischel, Timothy F Cloughesy, 2011, Cancer discovery.

mTORC2 links growth factor signaling with epigenetic regulation of iron metabolism in glioblastoma

T. Cloughesy, P. Mischel, W. Cavenee, 2019, The Journal of Biological Chemistry.

Oncogene Amplification in Growth Factor Signaling Pathways Renders Cancers Dependent on Membrane Lipid Remodeling.

T. Cloughesy, P. Mischel, W. Cavenee, 2019, Cell metabolism.

Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240

S. Vandenberg, C. James, R. DePinho, 2012, Proceedings of the National Academy of Sciences.

MiR-520b inhibits endothelial activation by targeting NF-κB p65-VCAM1 axis.

Jianfeng Huang, Xiangfeng Lu, D. Gu, 2021, Biochemical pharmacology.

The mTOR Kinase Inhibitors, CC214-1 and CC214-2, Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas

C. James, J. Heath, T. Cloughesy, 2013, Clinical Cancer Research.

Cancer Therapy : Preclinical The mTOR Kinase Inhibitors , CC 2141 and CC 2142 , Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas

C. James, J. Heath, T. Cloughesy, 2013 .

SOX 2 promotes the migration and invasion of laryngeal cancer cells by induction of MMP-2 via the PI 3 K / Akt / mTOR pathway

Yan Wang, Huijun Yang, N. Yang, 2014 .

Proteogenomics Integrating Reveal a Complex Network, Alternative Splicing, Hub Genes Regulating Heart Maturation

Guogang Zhang, Shen Song, Yu Nie, 2022, Genes.

Longitudinal evaluation of MPIO-labeled stem cell biodistribution in glioblastoma using high resolution and contrast-enhanced MR imaging at 14.1 tesla.

M. Berger, C. James, P. Mischel, 2012, Neuro-oncology.

Exosomes derived from miR-1228 overexpressing bone marrow-mesenchymal stem cells promote growth of gastric cancer cells

Huijun Yang, Li-li Chang, Shumei Zhang, 2021, Aging.

A Retrospective Cohort Study of Sublingual Immunotherapy with Standardized Dermatophagoides farinae Drops for Allergic Rhinitis

Jianyong Liu, Huijun Yang, Geping Wu, 2021, Advances in Therapy.

NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling

V. Bafna, P. Mischel, B. Ren, 2019, Nature.

Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance.

T. Cloughesy, P. Mischel, H. Vinters, 2011, Cancer discovery.

De-repression of PDGFRβ transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients.

P. Mischel, F. Tamanoi, W. Cavenee, 2013, Cancer discovery.